| positive regulation of cytokine production | GO:0001819 | 174 | 0.804 | |
| cation homeostasis | GO:0055080 | 212 | 0.514 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.427 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.394 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.323 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.321 | |
| axonogenesis | GO:0007409 | 274 | 0.320 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.310 | |
| t cell activation | GO:0042110 | 289 | 0.283 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.280 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.276 | |
| calcium ion transport | GO:0006816 | 159 | 0.270 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.262 | |
| chemotaxis | GO:0006935 | 247 | 0.258 | |
| synaptic transmission | GO:0007268 | 329 | 0.248 | |
| digestive tract development | GO:0048565 | 190 | 0.244 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.226 | |
| positive regulation of cytokine biosynthetic process | GO:0042108 | 40 | 0.215 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.212 | |
| cellular homeostasis | GO:0019725 | 240 | 0.209 | |
| immune effector process | GO:0002252 | 321 | 0.200 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.196 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.192 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.191 | |
| angiogenesis | GO:0001525 | 201 | 0.190 | |
| regulation of cell motility | GO:2000145 | 236 | 0.188 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.187 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.184 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.184 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.179 | |
| regulation of ion transport | GO:0043269 | 215 | 0.178 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.177 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.174 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.172 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.167 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.164 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.164 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.162 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.161 | |
| adaptive immune response | GO:0002250 | 155 | 0.160 | |
| cerebral cortex development | GO:0021987 | 86 | 0.159 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.155 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.153 | |
| granulocyte chemotaxis | GO:0071621 | 39 | 0.153 | |
| leukocyte migration | GO:0050900 | 124 | 0.150 | |
| telencephalon development | GO:0021537 | 186 | 0.150 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.148 | |
| regulation of system process | GO:0044057 | 200 | 0.148 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.147 | |
| amide transport | GO:0042886 | 138 | 0.143 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.142 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.140 | |
| muscle system process | GO:0003012 | 141 | 0.140 | |
| stem cell differentiation | GO:0048863 | 268 | 0.140 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.137 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.137 | |
| hormone secretion | GO:0046879 | 128 | 0.135 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.133 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.133 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.133 | |
| regionalization | GO:0003002 | 337 | 0.127 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.127 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.126 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.125 | |
| circulatory system process | GO:0003013 | 197 | 0.124 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.124 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.120 | |
| cytokine production | GO:0001816 | 319 | 0.120 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.119 | |
| cell chemotaxis | GO:0060326 | 81 | 0.117 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.113 | |
| neuron projection guidance | GO:0097485 | 141 | 0.112 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.111 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.111 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.110 | |
| sensory perception of pain | GO:0019233 | 47 | 0.110 | |
| ear morphogenesis | GO:0042471 | 118 | 0.110 | |
| action potential | GO:0001508 | 78 | 0.109 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.108 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.108 | |
| regulation of immunological synapse formation | GO:2000520 | 2 | 0.108 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.108 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.108 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.105 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.105 | |
| digestive system development | GO:0055123 | 200 | 0.104 | |
| mesenchyme development | GO:0060485 | 152 | 0.104 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.102 | |
| regulation of secretion | GO:0051046 | 274 | 0.102 | |
| cation transport | GO:0006812 | 399 | 0.101 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.100 | |
| hexose metabolic process | GO:0019318 | 98 | 0.099 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.099 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.099 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.096 | |
| inflammatory response | GO:0006954 | 244 | 0.095 | |
| t cell differentiation | GO:0030217 | 174 | 0.095 | |
| locomotory behavior | GO:0007626 | 195 | 0.094 | |
| granulocyte migration | GO:0097530 | 43 | 0.094 | |
| ear development | GO:0043583 | 200 | 0.093 | |
| peptide secretion | GO:0002790 | 114 | 0.092 | |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.091 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.091 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.091 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.090 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.089 | |
| muscle contraction | GO:0006936 | 101 | 0.089 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.089 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.089 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.089 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.089 | |
| b cell proliferation | GO:0042100 | 53 | 0.088 | |
| neuron migration | GO:0001764 | 122 | 0.087 | |
| immunoglobulin production | GO:0002377 | 73 | 0.087 | |
| defense response to bacterium | GO:0042742 | 119 | 0.086 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.086 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.086 | |
| positive regulation of monocyte extravasation | GO:2000439 | 1 | 0.086 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.085 | |
| regulation of cell migration | GO:0030334 | 219 | 0.085 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.085 | |
| ossification | GO:0001503 | 216 | 0.084 | |
| peptide transport | GO:0015833 | 133 | 0.084 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.084 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.083 | |
| response to acid chemical | GO:0001101 | 111 | 0.082 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.082 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.081 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.081 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.080 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.080 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.080 | |
| insulin secretion | GO:0030073 | 89 | 0.080 | |
| respiratory tube development | GO:0030323 | 167 | 0.080 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.080 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.080 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.079 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.078 | |
| axon guidance | GO:0007411 | 141 | 0.078 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.077 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.076 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.076 | |
| protein kinase c activating g protein coupled receptor signaling pathway | GO:0007205 | 4 | 0.075 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.075 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.075 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.075 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.075 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.075 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.074 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.074 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.073 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.073 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.073 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.073 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.072 | |
| organelle fission | GO:0048285 | 170 | 0.072 | |
| skeletal system development | GO:0001501 | 356 | 0.072 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.072 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.072 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.072 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.071 | |
| defense response to other organism | GO:0098542 | 197 | 0.071 | |
| pallium development | GO:0021543 | 120 | 0.071 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.070 | |
| glial cell differentiation | GO:0010001 | 131 | 0.070 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.069 | |
| blood circulation | GO:0008015 | 195 | 0.067 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.067 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.066 | |
| muscle tissue development | GO:0060537 | 308 | 0.065 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.065 | |
| oxidation reduction process | GO:0055114 | 342 | 0.065 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.065 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.065 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.064 | |
| monocyte extravasation | GO:0035696 | 2 | 0.063 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.063 | |
| gliogenesis | GO:0042063 | 141 | 0.062 | |
| eosinophil activation | GO:0043307 | 1 | 0.062 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.061 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.061 | |
| b cell activation | GO:0042113 | 161 | 0.061 | |
| glucose homeostasis | GO:0042593 | 128 | 0.061 | |
| hormone metabolic process | GO:0042445 | 86 | 0.061 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.061 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.061 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.061 | |
| forebrain cell migration | GO:0021885 | 58 | 0.060 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.060 | |
| nuclear division | GO:0000280 | 158 | 0.059 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.059 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.059 | |
| cell fate commitment | GO:0045165 | 210 | 0.059 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.058 | |
| cell adhesion | GO:0007155 | 329 | 0.058 | |
| positive regulation of monocyte chemotaxis | GO:0090026 | 2 | 0.058 | |
| blood coagulation | GO:0007596 | 76 | 0.058 | |
| positive regulation of t cell costimulation | GO:2000525 | 2 | 0.058 | |
| response to growth factor | GO:0070848 | 198 | 0.058 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.057 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.057 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.057 | |
| mature dendritic cell differentiation | GO:0097029 | 3 | 0.056 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.056 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.056 | |
| regulation of interleukin 1 production | GO:0032652 | 26 | 0.056 | |
| placenta development | GO:0001890 | 140 | 0.056 | |
| developmental maturation | GO:0021700 | 193 | 0.055 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.055 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 26 | 0.054 | |
| regulation of t cell costimulation | GO:2000523 | 2 | 0.054 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.053 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.053 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.053 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.053 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.053 | |
| cellular response to lipid | GO:0071396 | 145 | 0.053 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.052 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.052 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.052 | |
| regulation of b cell proliferation | GO:0030888 | 39 | 0.052 | |
| cell division | GO:0051301 | 120 | 0.051 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.051 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.050 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.050 | |
| cardiac chamber development | GO:0003205 | 108 | 0.050 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.050 | |
| circadian rhythm | GO:0007623 | 114 | 0.049 | |
| antigen processing and presentation | GO:0019882 | 47 | 0.049 | |
| tissue homeostasis | GO:0001894 | 115 | 0.049 | |
| glucose metabolic process | GO:0006006 | 92 | 0.049 | |
| plasma membrane organization | GO:0007009 | 90 | 0.049 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.049 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.048 | |
| mapk cascade | GO:0000165 | 281 | 0.048 | |
| heart morphogenesis | GO:0003007 | 178 | 0.048 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.048 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.048 | |
| positive regulation of t cell receptor signaling pathway | GO:0050862 | 4 | 0.047 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.047 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.047 | |
| respiratory system development | GO:0060541 | 190 | 0.047 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.047 | |
| regulation of tube size | GO:0035150 | 57 | 0.047 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.047 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.047 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.046 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.046 | |
| feeding behavior | GO:0007631 | 62 | 0.046 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.046 | |
| transmembrane transport | GO:0055085 | 412 | 0.046 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.046 | |
| lung morphogenesis | GO:0060425 | 50 | 0.046 | |
| striated muscle adaptation | GO:0014888 | 26 | 0.046 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.046 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.046 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.046 | |
| regulation of monocyte chemotaxis | GO:0090025 | 3 | 0.046 | |
| positive regulation of cell division | GO:0051781 | 31 | 0.045 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.045 | |
| exocytosis | GO:0006887 | 121 | 0.045 | |
| neutrophil migration | GO:1990266 | 37 | 0.045 | |
| acute inflammatory response | GO:0002526 | 41 | 0.045 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 26 | 0.045 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.045 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.044 | |
| stem cell development | GO:0048864 | 219 | 0.044 | |
| endocrine system development | GO:0035270 | 98 | 0.044 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.044 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.044 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.044 | |
| regulation of immunoglobulin mediated immune response | GO:0002889 | 37 | 0.044 | |
| lung development | GO:0030324 | 164 | 0.044 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.044 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.044 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.044 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.044 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.043 | |
| forebrain development | GO:0030900 | 302 | 0.043 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.043 | |
| extracellular structure organization | GO:0043062 | 148 | 0.043 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.043 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.043 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.043 | |
| positive regulation of t cell extravasation | GO:2000409 | 2 | 0.042 | |
| cerebral cortex cell migration | GO:0021795 | 44 | 0.042 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.042 | |
| regulation of saliva secretion | GO:0046877 | 2 | 0.042 | |
| developmental cell growth | GO:0048588 | 84 | 0.042 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.042 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.042 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.042 | |
| positive regulation of neutrophil migration | GO:1902624 | 12 | 0.042 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.042 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.042 | |
| operant conditioning | GO:0035106 | 2 | 0.041 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.041 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.041 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.041 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.041 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.041 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.041 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.041 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.041 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.040 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.040 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.040 | |
| ovulation cycle | GO:0042698 | 59 | 0.040 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.040 | |
| regulation of acute inflammatory response | GO:0002673 | 27 | 0.040 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.040 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.039 | |
| regulation of ossification | GO:0030278 | 112 | 0.039 | |
| maintenance of location | GO:0051235 | 89 | 0.039 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.039 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.039 | |
| adenylate cyclase inhibiting g protein coupled receptor signaling pathway | GO:0007193 | 20 | 0.039 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.038 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.038 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.038 | |
| positive regulation of calcium ion transport | GO:0051928 | 27 | 0.038 | |
| cartilage development | GO:0051216 | 140 | 0.038 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.038 | |
| histone modification | GO:0016570 | 159 | 0.038 | |
| wound healing | GO:0042060 | 157 | 0.038 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.037 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.037 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.037 | |
| synapse organization | GO:0050808 | 125 | 0.037 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.037 | |
| response to insulin | GO:0032868 | 100 | 0.037 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.037 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.037 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.037 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.037 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.037 | |
| helper t cell chemotaxis | GO:0035704 | 1 | 0.037 | |
| membrane organization | GO:0061024 | 245 | 0.036 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.036 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.036 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.036 | |
| cell growth | GO:0016049 | 130 | 0.036 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.035 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.035 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.035 | |
| defense response to virus | GO:0051607 | 68 | 0.035 | |
| t helper 17 cell chemotaxis | GO:0035705 | 1 | 0.035 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.035 | |
| face development | GO:0060324 | 38 | 0.035 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.034 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.034 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.034 | |
| bundle of his development | GO:0003166 | 4 | 0.034 | |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 50 | 0.034 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.034 | |
| eosinophil mediated immunity | GO:0002447 | 1 | 0.034 | |
| positive regulation of granulocyte chemotaxis | GO:0071624 | 12 | 0.034 | |
| chromatin modification | GO:0016568 | 187 | 0.034 | |
| hindbrain development | GO:0030902 | 128 | 0.034 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.034 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.034 | |
| rhythmic process | GO:0048511 | 174 | 0.033 | |
| interleukin 8 production | GO:0032637 | 4 | 0.033 | |
| regulation of tumor necrosis factor production | GO:0032680 | 49 | 0.033 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.033 | |
| optic nerve development | GO:0021554 | 8 | 0.033 | |
| negative regulation of growth | GO:0045926 | 99 | 0.033 | |
| somatostatin receptor signaling pathway | GO:0038169 | 2 | 0.033 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.032 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.032 | |
| positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway | GO:0010579 | 3 | 0.032 | |
| dna metabolic process | GO:0006259 | 303 | 0.032 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.032 | |
| cognition | GO:0050890 | 149 | 0.032 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.032 | |
| eosinophil migration | GO:0072677 | 3 | 0.032 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.032 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.032 | |
| cytokine secretion | GO:0050663 | 72 | 0.032 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.032 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.032 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.032 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.032 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.032 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.032 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.032 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.032 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.031 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.031 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.031 | |
| gland development | GO:0048732 | 330 | 0.031 | |
| hypersensitivity | GO:0002524 | 10 | 0.031 | |
| regulation of t cell extravasation | GO:2000407 | 3 | 0.031 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.031 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.031 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.031 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.031 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.031 | |
| camera type eye development | GO:0043010 | 266 | 0.031 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.031 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.031 | |
| associative learning | GO:0008306 | 61 | 0.031 | |
| acetylcholine secretion neurotransmission | GO:0014055 | 2 | 0.031 | |
| activation of mapk activity | GO:0000187 | 59 | 0.031 | |
| endoderm development | GO:0007492 | 45 | 0.031 | |
| regulation of resting membrane potential | GO:0060075 | 3 | 0.031 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.031 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.030 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.030 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.030 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.030 | |
| renal system development | GO:0072001 | 225 | 0.030 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.030 | |
| response to oxygen levels | GO:0070482 | 62 | 0.030 | |
| monoamine transport | GO:0015844 | 33 | 0.030 | |
| germ cell development | GO:0007281 | 185 | 0.030 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.030 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.030 | |
| muscle cell development | GO:0055001 | 133 | 0.030 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.030 | |
| interleukin 12 secretion | GO:0072610 | 3 | 0.030 | |
| cell maturation | GO:0048469 | 127 | 0.029 | |
| pancreas development | GO:0031016 | 57 | 0.029 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.029 | |
| neuronal action potential | GO:0019228 | 54 | 0.029 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.029 | |
| embryonic placenta development | GO:0001892 | 98 | 0.029 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.029 | |
| neuromuscular process | GO:0050905 | 99 | 0.029 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.029 | |
| digestion | GO:0007586 | 40 | 0.029 | |
| methylation | GO:0032259 | 134 | 0.029 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.029 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.029 | |
| somatostatin signaling pathway | GO:0038170 | 2 | 0.029 | |
| conditioned taste aversion | GO:0001661 | 4 | 0.028 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.028 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.028 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.028 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.028 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.028 | |
| regulation of acetylcholine secretion neurotransmission | GO:0014056 | 2 | 0.028 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.028 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.028 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.028 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.028 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.028 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.028 | |
| eosinophil degranulation | GO:0043308 | 1 | 0.028 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.028 | |
| cd8 positive alpha beta t cell extravasation | GO:0035697 | 3 | 0.028 | |
| regulation of cell activation | GO:0050865 | 289 | 0.028 | |
| immune complex clearance | GO:0002434 | 2 | 0.028 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.028 | |
| sensory perception | GO:0007600 | 245 | 0.028 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.027 | |
| heart process | GO:0003015 | 94 | 0.027 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.027 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.027 | |
| regulation of neuron death | GO:1901214 | 134 | 0.027 | |
| notch signaling pathway | GO:0007219 | 71 | 0.027 | |
| tumor necrosis factor biosynthetic process | GO:0042533 | 10 | 0.027 | |
| regulation of tumor necrosis factor biosynthetic process | GO:0042534 | 10 | 0.027 | |
| biomineral tissue development | GO:0031214 | 64 | 0.027 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.027 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.027 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.026 | |
| neuron death | GO:0070997 | 154 | 0.026 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.026 | |
| interleukin 1 secretion | GO:0050701 | 16 | 0.026 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.026 | |
| cell recognition | GO:0008037 | 83 | 0.026 | |
| regulation of immune complex clearance by monocytes and macrophages | GO:0090264 | 2 | 0.026 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.026 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.026 | |
| response to inorganic substance | GO:0010035 | 96 | 0.026 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.026 | |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.026 | |
| negative regulation of leukocyte mediated immunity | GO:0002704 | 29 | 0.026 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.025 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.025 | |
| positive regulation of b cell activation | GO:0050871 | 49 | 0.025 | |
| regulation of g protein coupled receptor protein signaling pathway | GO:0008277 | 37 | 0.025 | |
| heart growth | GO:0060419 | 45 | 0.025 | |
| exocrine system development | GO:0035272 | 45 | 0.025 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.025 | |
| response to nutrient levels | GO:0031667 | 109 | 0.025 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.025 | |
| positive regulation of ion transmembrane transporter activity | GO:0032414 | 15 | 0.025 | |
| gastrulation | GO:0007369 | 116 | 0.025 | |
| regulation of neutrophil migration | GO:1902622 | 14 | 0.025 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.025 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.025 | |
| macrophage chemotaxis | GO:0048246 | 14 | 0.025 | |
| positive regulation of glycoprotein metabolic process | GO:1903020 | 6 | 0.025 | |
| hemostasis | GO:0007599 | 78 | 0.025 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.024 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.024 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.024 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.024 | |
